rosiglitazone has been researched along with zinc protoporphyrin ix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, BR; Blüml, S; Bochkov, VN; Exner, M; Fürnkranz, A; Ikonomu, E; Kadl, A; Krönke, G; Leitinger, N; Sarembock, IJ | 1 |
| De Benedictis, L; De Salvia, MA; Gagliardi, S; Montagnani, M; Potenza, MA; Zigrino, A | 1 |
2 other study(ies) available for rosiglitazone and zinc protoporphyrin ix
| Article | Year |
|---|---|
Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.
Topics: Anti-Inflammatory Agents; Cell Proliferation; Cells, Cultured; Chromans; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Heme Oxygenase-1; Humans; Membrane Proteins; Metalloporphyrins; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Polymorphism, Genetic; PPAR alpha; PPAR gamma; Promoter Regions, Genetic; Protoporphyrins; Pyrimidines; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors; Transcription, Genetic; Transfection; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
Rosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats.
Topics: Animals; Carbon Monoxide; Duodenum; Gastrointestinal Motility; Heme Oxygenase (Decyclizing); Hypoglycemic Agents; Isoenzymes; Male; Nitric Oxide; Nitric Oxide Synthase; Protoporphyrins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Synaptic Transmission; Thiazolidinediones | 2012 |